Literature DB >> 3028268

Mitogen-stimulated release of inositol phosphates in human fibroblasts.

G A Jamieson, M L Villereal.   

Abstract

Mitogenic stimulation of quiescent human fibroblasts (HSWP) with a growth factor mixture (consisting of epidermal growth factor (EGF), insulin, bradykinin, and vasopressin) rapidly induces an increase in Na influx via a Ca-mediated activation of an amiloride-sensitive Na/H exchanger. Inositol phosphates (specifically inositol-1',4',5'-phosphate) have been implicated in mediating the mobilization of intracellular Ca stores in other cell types and we have now completed a detailed analysis of the mitogen-induced release of inositol phosphates in HSWP cells. Stimulation of inositol trisphosphate release is rapid (within 5 s) and reaches a maximum level (416-485% basal) within 10-15 s after the addition of growth factor mixture. Inositol bisphosphate and inositol monophosphate reach maximum levels by 30 s (1257% basal) and 60 s (291% basal), respectively. Levels of all three compounds then decay toward basal levels but remain elevated (150-350% of basal levels) after 10 min of incubation with mitogens. The effects of different combinations of these growth factors and of the bee venom peptide, melittin, have also been determined. We have also found that 8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate, which prevents the mitogen-induced rise in intracellular calcium activity and activation of Na influx, does not alter the mitogen-stimulated accumulation of inositol trisphosphate. In addition, the calcium ionophore A23187, which increases cytosolic Ca activity and induces a Na influx, does not stimulate the release of inositol trisphosphate. Assays performed in the presence of lithium, which inhibits inositol phosphate monophosphatase, promotes the prolonged and enhanced accumulation of inositol monophosphate. Treatment with the phospholipase inhibitor mepacrine or pretreatment with dexamethasone reduces the amount of inositol phosphates released upon mitogenic stimulation. Hence mitogenic stimulation of HSWP cells leads to the rapid stimulation of inositol phosphate release via a calcium-independent mechanism and suggests inositol trisphosphate as a candidate to mediate the release of intracellular calcium stores which is involved in the processes responsible for the activation of the Na/H exchanger.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3028268     DOI: 10.1016/0003-9861(87)90054-3

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  6 in total

1.  Estrogen-induced activation of mitogen-activated protein kinase requires mobilization of intracellular calcium.

Authors:  T Improta-Brears; A R Whorton; F Codazzi; J D York; T Meyer; D P McDonnell
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-13       Impact factor: 11.205

2.  Transduction of the bradykinin response in human fibroblasts: prolonged elevation of diacylglycerol level and its correlation with protein kinase C activation.

Authors:  B G Etscheid; K A Albert; M L Villereal; H C Palfrey
Journal:  Cell Regul       Date:  1991-03

3.  Phenytoin-induced DNA synthesis and inositol 1,4,5-trisphosphate formation in L-929 fibroblasts.

Authors:  R E Dill; G R Farmer
Journal:  Experientia       Date:  1991-07-15

4.  Alterations in intracellular calcium transients of fibroblasts from progressive systemic sclerotic patients: a digital imaging microscopic study.

Authors:  M Seishima; Y Kudo; S Nagao; S Mori; Y Nozawa
Journal:  Arch Dermatol Res       Date:  1991       Impact factor: 3.017

5.  Decreased bradykinin binding sites in fibroblasts from progressive systemic scleroderma.

Authors:  T Ozeki; K Osada; M Seishima; S Mori; Y Nozawa
Journal:  Arch Dermatol Res       Date:  1994       Impact factor: 3.017

6.  Bradykinin-induced Ca2+ signaling in human subcutaneous fibroblasts involves ATP release via hemichannels leading to P2Y12 receptors activation.

Authors:  Ana Rita Pinheiro; Diogo Paramos-de-Carvalho; Mariana Certal; Cristina Costa; Maria Teresa Magalhães-Cardoso; Fátima Ferreirinha; Maria Adelina Costa; Paulo Correia-de-Sá
Journal:  Cell Commun Signal       Date:  2013-09-18       Impact factor: 5.712

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.